{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:43:32Z","timestamp":1792190612643,"version":"4.4.0"},"reference-count":25,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/100012569","name":"University of Toledo","doi-asserted-by":"publisher","award":["This work was funded in part by University of Toledo, College of Medicine and Life Sciences grants (JCJ)"],"award-info":[{"award-number":["This work was funded in part by University of Toledo, College of Medicine and Life Sciences grants (JCJ)"]}],"id":[{"id":"10.13039\/100012569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-018-0483-y","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T03:15:37Z","timestamp":1546917337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer"],"prefix":"10.1136","volume":"7","author":[{"given":"Shahnawaz","family":"Imam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pervaiz","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodis","family":"Paparodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Almotah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Khudhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Abdul-Moiz","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-331X","authenticated-orcid":false,"given":"Juan Carlos","family":"Jaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"483_CR1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.188.9.1641","volume":"188","author":"P Romero","year":"1998","unstructured":"Romero P, Dunbar PR, Valmori D, Pittet M, Ogg GS, Rimoldi D, et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med. 1998;188:1641\u201350.","journal-title":"J Exp Med"},{"key":"483_CR2","first-page":"1743","volume":"62","author":"D Valmori","year":"2002","unstructured":"Valmori D, Scheibenbogen C, Dutoit V, Nagorsen D, Asemissen AM, et al. Circulating tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(\u2212) effector subset exerting ex vivo tumor-specific cytolytic activity. Cancer Res. 2002;62:1743\u201350.","journal-title":"Cancer Res"},{"key":"483_CR3","unstructured":"Jaume JC. Endocrine Autoimmunity. In: Greenspans\u2019 Basic and Clinical Endocrinology, edn 9, Eds GC Gardner & DM Shoback. New York: McGraw-Hill Medical; 2017. P. 27\u201346."},{"key":"483_CR4","first-page":"582","volume":"6","author":"A Korman","year":"2005","unstructured":"Korman A, Yellin M, Keler T. Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies. Curr Opin Investig Drugs. 2005;6:582\u201391.","journal-title":"Curr Opin Investig Drugs"},{"key":"483_CR5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","volume":"354","author":"H Gogas","year":"2006","unstructured":"Gogas H, Ioannovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med. 2006;354:709\u201318.","journal-title":"N Engl J Med"},{"key":"483_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrendo.2016.205","volume":"13","author":"DJ Byun","year":"2017","unstructured":"Byun DJ, Wolchok JD, Rosenberg LM, Girotra M. Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol. 2017;13:195\u2013207.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"483_CR7","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.4158\/EP161410.CR","volume":"3","author":"JB Hao","year":"2017","unstructured":"Hao JB, Renno A, Imam S, Alfonso-Jaume MA, Elnagar N, Jaume JC. Development of type 1 diabetes after Cancer immunotherapy. AACE Clinical Case Reports: Summer. 2017;3(3):e242\u20135.","journal-title":"AACE Clinical Case Reports: Summer"},{"key":"483_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","volume":"7","author":"F Balkwill","year":"2005","unstructured":"Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211\u20137.","journal-title":"Cancer Cell"},{"key":"483_CR9","doi-asserted-by":"crossref","unstructured":"Chen H, Schneider D, Mazeh H, Jaume JC, Lubner S Cancer of the Endocrine System. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds) Abeloff\u2019s Clinical Oncology, 5th edition. Churchill Livingstone Elsevier, Philadelphia, PA; 2013. p. 1112\u20131142.","DOI":"10.1016\/B978-1-4557-2865-7.00071-0"},{"issue":"7","key":"483_CR10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/thy.2013.0588","volume":"24","author":"R Paparodis","year":"2014","unstructured":"Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC. Hashimoto's thyroiditis pathology and risk for thyroid cancer. Thyroid. 2014;24(7):1107\u201314.","journal-title":"Thyroid"},{"key":"483_CR11","unstructured":"Paparodis R, Jaume JC. Thyroid Cancer Features in the Setting of Graves Disease. The Endocrine Society (ENDO 2014) (abstract)."},{"issue":"6","key":"483_CR12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.amjoto.2014.04.013","volume":"35","author":"AB Ergin","year":"2014","unstructured":"Ergin AB, Saralaya S, Olansky L. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience. Am J Otolaryngol. 2014;35(6):784\u201390.","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"483_CR13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1210\/jc.2012-2843","volume":"98","author":"G Pellegriti","year":"2013","unstructured":"Pellegriti G, Mannarino C, Russo M, Terranova R, Marturano I, Vigneri R, et al. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease. J Clin Endocrinol Metab. 2013;98(3):1014\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"483_CR14","first-page":"205","volume":"28","author":"DJ Stocker","year":"2003","unstructured":"Stocker DJ, Burch HB. Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinol. 2003;28(3):205\u201312.","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"483_CR15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-13-0436","volume":"21","author":"S Imam","year":"2014","unstructured":"Imam S, Paparodis R, Sharma D, Jaume JC. Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity. Endocr Relat Cancer. 2014;21(3):505\u201316.","journal-title":"Endocr Relat Cancer"},{"key":"483_CR16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958\u201369.","journal-title":"Nat Rev Immunol"},{"issue":"50","key":"483_CR17","doi-asserted-by":"crossref","first-page":"21659","DOI":"10.1073\/pnas.1007654108","volume":"107","author":"F Bellora","year":"2010","unstructured":"Bellora F, Castriconi R, Dondero A, Reggiardo G, Moretta L, Mantovani A, et al. The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc Natl Acad Sci U S A. 2010;107(50):21659\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"483_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen J, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. [Published erratum appears in 2014 Immunity. 41: 339\u2013340.]. Immunity. 2014;41:14\u201320.","journal-title":"Immunity"},{"key":"483_CR19","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.1500325","volume":"195","author":"I Mattiola","year":"2015","unstructured":"Mattiola I, Pesant M, Tentorio PF, Molgora M, Marcenaro E, Lugli E, et al. Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1\u03b2, IFN-\u03b2, and IL-15 pathways. J Immunol. 2015;195:2818\u201328.","journal-title":"J Immunol"},{"key":"483_CR20","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.4049\/jimmunol.149.8.2709","volume":"149","author":"CD Mills","year":"1992","unstructured":"Mills CD, Shearer J, Evans R, Caldwell MD. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J Immunol. 1992;149:2709\u201314.","journal-title":"J Immunol"},{"key":"483_CR21","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","volume":"331","author":"GL Beatty","year":"2011","unstructured":"Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science. 2011;331:1612\u20136.","journal-title":"Science"},{"key":"483_CR22","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20112738","volume":"209","author":"T O'Sullivan","year":"2012","unstructured":"O'Sullivan T, Saddawi-Konefka R, Vermi W, Koebel CM, Arthur C, White JM, et al. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med. 2012;209:1869\u201382.","journal-title":"J Exp Med"},{"issue":"7","key":"483_CR23","doi-asserted-by":"crossref","first-page":"e22567","DOI":"10.1371\/journal.pone.0022567","volume":"6","author":"B Caillou","year":"2011","unstructured":"Caillou B, Talbot M, Weyemi U, Pioche-Durieu C, Al Ghuzlan A, Bidart JM, et al. Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma. PLoS One. 2011;6(7):e22567.","journal-title":"PLoS One"},{"issue":"11","key":"483_CR24","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/ijc.30387","volume":"139","author":"XJ Li","year":"2016","unstructured":"Li XJ, Gangadaran P, Kalimuthu S, Oh JM, Zhu L, Jeong SY, et al. Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer. Int J Cancer. 2016;139(11):2583\u201392.","journal-title":"Int J Cancer"},{"issue":"9","key":"483_CR25","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1038\/emm.2017.172","volume":"49","author":"IA Hajam","year":"2017","unstructured":"Hajam IA, Dar PA, Shahnawaz I, Jaume JC, Lee JH. Bacterial flagellin-a potent immunomodulatory agent. Exp Mol Med. 2017;49(9):e373.","journal-title":"Exp Mol Med"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0483-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T18:49:06Z","timestamp":1694544546000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-018-0483-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1186\/s40425-018-0483-y","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"article-number":"3"}}